Fitness for radical treatment of Lung cancer patients

Breathe

Volumn 7, Issue 3, 2011, Pages 221-228

  Charloux, A ^a  

^a UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GEMCITABINE; TAXANE DERIVATIVE;

6 MINUTE WALK TEST; ANAMNESIS; CANCER MORTALITY; CANCER PATIENT; CANCER THERAPY; CARDIOPULMONARY EXERCISE TEST; CARDIOVASCULAR SYSTEM EXAMINATION; CHEMORADIOTHERAPY; CREATININE BLOOD LEVEL; ELECTROCARDIOGRAM; EXERCISE; EXERCISE TEST; FITNESS; FORCED EXPIRATORY VOLUME; HUMAN; LUNG CANCER; LUNG CAPACITY; LUNG FUNCTION TEST; LUNG RESECTION; LUNG TOXICITY; PERIOPERATIVE PERIOD; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PREOPERATIVE EVALUATION; RADIATION INJURY; REVIEW; REVISED CARDIAC RISK INDEX; SCORING SYSTEM; SHUTTLE TEST; STAIR CLIMBING TEST;

EID: 79953680157     PISSN: 18106838     EISSN: 20734735     Source Type: Journal    
DOI: 10.1183/20734735.021410     Document Type: Review

References (40)

1. Tisi GM. Preoperative evaluation of pulmonary function. Validity, indications, and benefits. Am Rev Respir Dis 1979; 119: 293-310.
2. Olsen GN, Block AJ, Tobias JA. Prediction of postpneumonectomy pulmonary function using quantitative macroaggregate lung scanning. Chest 1974; 66: 13-16.
3. Bolliger CT, Soler M, Stulz P, et al. Evaluation of high-risk lung resection candidates: pulmonary haemodynamics versus exercise testing. A series of five patients. Respiration 1994; 61: 181-186.
4. Brunelli A, Charloux A, Bolliger CT, et al. ERS/ESTS clinical guidelines on fitness for radical therapy in lung cancer patients (surgery and chemo-radiotherapy). Eur Respir J 2009; 34: 17-41.
5. Lim E, Baldwin D, Beckles M, et al. Guidelines on the radical management of patients with lung cancer. Thorax 2010; 65:Suppl. 3, iii1-iii27.
6. Colice GL, Shafazand S, Griffin JP, et al. Physiologic evaluation of the patient with lung cancer being considered for resectional surgery: ACCP evidenced-based clinical practice guidelines (2nd edition). Chest 2007; 132:Suppl., 161S-177S.
7. Ginsberg RJ. Lung cancer surgery: acceptable morbidity and mortality, expected results and quality control. Surg Oncol 2002; 11: 263-266.
8. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation 1999; 100: 1043-1049.
9. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for pre-operative cardiac risk assessment and perioperative cardiac management in non-cardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Non-cardiac Surgery of the European Society of Cardiology (ESC) and European Society of Anaesthesiology (ESA). Eur Heart J 2009; 30: 2769-2812.
10. Licker M, Schnyder JM, Frey JG, et al. Impact of aerobic exercice capacity and procedure-related factors in lung cancer surgery. Eur Respir J 2010 [Epub ahead of print DOI: 10.1183/09031936.00069910]
11. Liptay MJ, Basu S, Hoaglin MC, et al. Diffusion lung capacity for carbon monoxide (DLCO) is an independent prognostic factor for long-term survival after curative lung resection for cancer. J Surg Oncol 2009; 100: 703-707.
12. Ferguson MK, Vigneswaran WT. Diffusing capacity predicts morbidity after lung resection in patients without obstructive lung disease. Ann Thorac Surg 2008; 85: 1158-1164.
13. British Thoracic Society, Society of Cardiothoracic Surgeons of Great Britain and Ireland Working Party. BTS guidelines: guidelines on the selection of patients with lung cancer for surgery. Thorax 2001; 56: 89-108.
14. Beckles MA, Spiro SG, Colice GL, et al. The physiologic evaluation of patients with lung cancer being considered for resectional surgery. Chest 2003; 123:Suppl., 105S-114S.
15. Bolliger CT, Perruchoud AP. Functional evaluation of the lung resection candidate. Eur Respir J 1998; 11: 198-212.
16. Brunelli A. Algorithm for functional evaluation of lung resection candidates: time for reappraisal? Respiration 2009; 78: 117-118.
17. 02 measurement for lung resection candidates: results of Cancer and Leukemia Group B Protocol 9238. J Thorac Oncol 2007; 2: 619-625.
18. CO less than 40%. Chest 2010; [Epub ahead of print DOI: 10.1378/chest.10-1069]
19. Wyser C, Stulz P, Soler M, et al. Prospective evaluation of an algorithm for the functional assessment of lung resection candidates. Am J Respir Crit Care Med 1999; 159: 1450-1456.
20. Benzo RP, Sciurba FC. Oxygen consumption, shuttle walking test and the evaluation of lung resection. Respiration 2010; 80: 19-23.
21. Win T, Jackson A, Groves AM, et al. Comparison of shuttle walk with measured peak oxygen consumption in patients with operable lung cancer. Thorax 2006; 61: 57-60.
22. Brunelli A, Xiume F, Refai M, et al. Peak oxygen consumption measured during the stair-climbing test in lung resection candidates. Respiration 2010; 80: 207-211.
23. Koegelenberg CF, Diacon AH, Irani S, et al. Stair climbing in the functional assessment of lung resection candidates. Respiration 2008; 75: 374-379.
24. Brunelli A, Monteverde M, Al Refai M, et al. Stair climbing test as a predictor of cardiopulmonary complications after pulmonary lobectomy in the elderly. Ann Thorac Surg 2004; 77: 266-270.
25. Zollinger A, Hofer CK, Pasch T. Preoperative pulmonary evaluation: facts and myths. Curr Opin Anaesthesiol 2001; 14: 59-63.
26. Mason DP, Subramanian S, Nowicki ER, Grab, et al. Impact of smoking cessation before resection of lung cancer: a Society of Thoracic Surgeons General Thoracic Surgery Database study. Ann Thorac Surg 2009; 88: 362-370.
27. Shannon VR. Role of pulmonary rehabilitation in the management of patients with lung cancer. Curr Opin Pulm Med 2010; 16: 334-339.
28. Fishman A, Martinez F, Naunheim K, et al. A randomized trial comparing lung-volume-reduction surgery with medical therapy for severe emphysema. New Eng J Med 2003; 348: 2059-2073.
29. Choong CK, Mahesh B, Patterson GA, et al. Concomitant lung cancer resection and lung volume reduction surgery. Thorac Surg Clin 2009; 19: 209-216.
30. Atkins BZ, Harpole DH Jr, Mangum JH, et al. Pulmonary segmentectomy by thoracotomy or thoracoscopy: reduced hospital length of stay with a minimally-invasive approach. Ann Thorac Surg 2007; 84: 1107-1112.
31. Balsara KR, Balderson SS, D'Amico TA. Surgical techniques to avoid parenchymal injury during lung resection (fissureless lobectomy). Thorac Surg Clin 2010; 20: 365-369.
32. Paul S, Altorki NK, Sheng S, et al. Thoracoscopic lobectomy is associated with lower morbidity than open lobectomy: a propensity-matched analysis from the STS database. J Thorac Cardiovasc Surg 2010; 139: 366-378.
33. Scott WJ, Allen MS, Darling G, et al. Video-assisted thoracic surgery versus open lobectomy for lung cancer: a secondary analysis of data from the American College of Surgeons Oncology Group Z0030 randomized clinical trial. J Thorac Cardiovasc Surg 201; 139: 976-981.
34. Berry MF, Villamizar-Ortiz NR, Tong BC, et al. Pulmonary function tests do not predict pulmonary complications after thoracoscopic lobectomy. Ann Thorac Surg 2010; 89: 1044-1051.
35. Leo F, Pelosi G, Sonzogni A, et al. Structural lung damage after chemotherapy fact or fiction? Lung Cancer 2010; 67: 306-310.
36. Rivera MP, Detterbeck FC, Socinski MA, et al. Impact of preoperative chemotherapy on pulmonary function tests in resectable early-stage non-small cell lung cancer. Chest 2009; 135: 1588-1595.
37. Cerfolio RJ, Talati A, Bryant AS. Changes in pulmonary function tests after neoadjuvant therapy predict postoperative complications. Ann Thorac Surg 2009; 88: 930-935.
38. Cerfolio RJ, Bryant AS, Jones VL, et al. Pulmonary resection after concurrent chemotherapy and high dose (60Gy) radiation for non-small cell lung cancer is safe and may provide increased survival. Eur J Cardiothorac Surg 2009; 35: 718-723.
39. Marks LB, Bentzen SM, Deasy JO, et al. Radiation dose-volume effects in the lung. Int J Radiat Oncol Biol Phys 2010; 76:Suppl., S70-S76.
40. Dehing-Oberije C, De Ruysscher D, van Baardwijk A, et al. The importance of patient characteristics for the prediction of radiation-induced lung toxicity. Radiother Oncol 2009; 91: 421-426.